Needham Reiterates Buy on DocGo, Maintains $3 Price Target
Needham analyst Ryan MacDonald reiterates DocGo (NASDAQ:DCGO) with a Buy and maintains $3 price target.
Stocks · News reference
8-K filing — DocGo Inc. (DCGO)
Filed: 2026-10-05 AccNo: 0001628280-26-064740 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 1.02: Termination of a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 3.02: Unregistered Sales of Equity Securities Item 8.01: Other Events
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
DocGo shares are trading lower after the company reported worse-than-expected Q2 financial results and narrowed its FY2026 sales guidance.
Transcript: DocGo Q2 2026 Earnings Conference Call
DocGo (NASDAQ:DCGO) reported second-quarter financial results on Monday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by Benzinga APIs. For